Ankita Kaushik
Summary
High performing professional seeking an ambitious position wherein I can apply my skills in designing and executing value evidence and access strategies that will support access, reimbursement/ policy and have an impact on patient health outcomes.
Overview
23
23
years of professional experience
Work History
Senior Director and HEOR TA head
Gilead Sciences
01.2023 - Current
- Leading a high-performing team that develops and executes HEOR and market access strategies for in-line and pipeline oncology products
- Drove impactful reimbursement outcomes for Trodelvy in HR+/HER2- for Germany, France, and Nordics, Asia Pacific regions
- Supported launch strategy and deliverables for various oncology indications
- Played an instrumental role in driving patient reported outcomes strategy, observational research strategy, market shaping and policy initiatives
- Cultivated a culture of innovation by promoting creative thinking and encouraging employees to take calculated risks in pursuit of solutions.
- Developed strong relationships with key industry partners, fostering collaboration and mutual growth opportunities.
Senior Director and Access Strategy lead secondment
Gilead Sciences
03.2024 - 12.2024
- Actively shaped oncology team's strategies, priorities, and activities and influenced decision making on key cross-functional leadership teams
- Regularly partnered with global HEOR, pricing, marketing, medical, clinical, regulatory and local affiliate teams
- Refined global value & access strategy for breast TNBC and HR+ indications , including indication sequencing trade-offs and anticipated value evolution.
- Developed inputs for country launch sequence prioritization for 1LTNBC indications aligned with program strategy and balanced by regulatory & reimbursement timelines, reference pricing impact considerations.
- Partnered with German market access team to obtain early G-BA advice and leveraged feedback to influence evidence generation plans for launch indications for breast.
Senior Director and HEOR TA head
Gilead Sciences
01.2022 - 12.2022
- Led the development and execution of HEOR strategy for rare disease compound -Hepcludex
- Developed and disseminated relevant RWE needed to demonstrate product value proposition
- Supported HTA/reimbursement submissions for UK, Sweden, Canada, Australia
- Led a team of HEOR professionals who developed HEOR strategy and execution for pipeline assets including HBV cure program, Hepatitis C, NASH, PSC and Inflammation assets
Director and Virology HEOR lead
Gilead Sciences
07.2020 - 01.2022
- Leading the value evidence and strategy for inline products and tactics including real world evidence, dynamic transmission modelling and economic modelling for inline product for Hepatitis B and C
- Led policy shaping initiatives to demonstrate value of a cure innovation
Director and Retina Lead
Allergan
02.2019 - 06.2020
- Leading the value evidence and strategy for three ophthalmology products in various stages of development
- Executed value evidence strategy and supported HTA and reimbursement submission work
- Supported European Medical Agency (EMA) regulatory assessment by demonstrating value of product via network meta-analysis versus competition, and analysis to support product label
- Developed high-performing teams by providing mentorship, guidance, and opportunities for professional growth.
- Fostered cross functional collaboration among internal and external stakeholders by participation in investigator meetings, presentation at advisory board meetings, development and implementation of publication strategy, working with patient advocacy groups to develop a patient centered outcomes research strategy, worked with key opinion leaders to generate real world evidence and post hoc analysis based on clinical trial data,
Director
Merck & Co., Inc.
07.2012 - 01.2019
- Developed and executed outcomes research strategies/plans for supporting products and indications in clinical areas of Osteoporosis, Oncology and Insomnia
- Worked closely with marketing, public affairs and communications team
- As member of Global Access Team, critically assessed drivers and barriers to pricing, reimbursement, and market access and provided input into clinical and market development programs. Worked closely with Access & Pricing colleagues to develop global & country-specific access and reimbursement strategies.
- ·Presented outcomes research data at several international/national congresses via abstracts, posters and podium presentations and published >30 articles in scientific journals.
- Instrumental in building big data capabilities and disease cohorts for Healthcare organizations (e.g., Regenstrief and Maccabi health systems)
- Developed high-performing teams by providing mentorship, guidance, and opportunities for professional growth.
Associate Manager
Merck Sharp and Dohme
08.2010 - 07.2012
- Planning, designing and conducting outcomes research studies and scientific leader engagement
- Support Global reimbursement and market access for Merck Osteoporosis portfolio
Graduate Research Assistant
Purdue University
08.2007 - 05.2010
- Conducted literature reviews and retrospective database analysis
- Prepared manuscripts for publication
Intern
Pfizer
06.2007 - 08.2007
- Economic modeling and review of clinical data.
Graduate Teaching Assistant
Purdue University
08.2006 - 05.2007
- Moderated discussions on journal articles
- Assisted in teaching a course at the undergraduate level
Graduate Research Assistant
Purdue University
08.2005 - 07.2006
- Conducted literature reviews and completed cost of treatment analysis.
Graduate Assistant
University of Louisiana at Monroe
01.2004 - 08.2005
- Supervised a computer learning class for Pharm.D Students.
- Supervised pharmacy practical labs for first professional year pharmacy students, including management of course material, and facilitation of student projects.
Summer Intern
Indoco Remedies
05.2002 - 07.2002
- Worked in manufacturing, testing and quality assurance departments.
Education
Ph. D - Pharmacy
Purdue University
West Lafayette, IN05.2010
Master of Science - Pharmacy
University of Louisiana at Monroe
Monroe, LA08.2005
Bachelor in Pharmaceutical Sciences -
University of Mumbai
07.2003
Skills
- Health Outcomes Research
- Health Economics
- Big Data/Real World Evidence
- Epidemiology
- Value evidence for HTA
- Research Methods and Design
- Market Access Strategy
- Global Pricing and Reimbursement
- Retrospective & prospective Database Analysis
- Statistical methodology
- Manuscript Preparation
- Effective communication skills
- Statistical Software: SAS, SPSS, STATA, EndNote
Websites
Continuing Education
- 10/17, Immuno-oncology: An introductory overview, Marriott Newark Airport, USA
- 05/07, Use of Instrumental Variables in Observational Studies of Treatment Effects, ISPOR, Arlington, VA, USA
- 05/08, Cost-Effectiveness Analysis Alongside Clinical Trials, ISPOR, Toronto, Canada
- 05/09, Use of Propensity Scores in Observational Studies of Treatment Effects, ISPOR, Orlando, FL, USA
- 11/2024, Use of external control arm data for HTA decision making, ISPOR, Spain
- 11/2024, Oncology survival modelling, ISPOR, Spain
Recognition Awards
- 2022-2024, Awarded key contributor stock award at Gilead
- 2018, Awarded at Merck for Focus on Customers including Patients at Aspirational Workshop for Belsomra in Japan
- 2018 Awarded at Merck for Focus on Customers including Patients at Aspirational Workshop for Belsomra in Japan
- 2015 Merck Retention Award(2 years retention)
- 2015 Full Member of Sigma Xi Scientific Research Society
- 2015 Award of Excellence for exceptional cross-functional collaboration between Global Health Outcomes, Epidemiology, Global Market Access, US Payor Marketing and Global Medical Affairs teams for running the 4th hurdle meeting for Osteoporosis compound
- 2014 Poster won Gold medal at AMCP 2014 Fall Meeting
- 2014 Poster won Platinum medal at AMCP 2014 Fall Meeting
- 2013 Award of Excellence for Best collaboration between Global Health Outcomes and Payer Marketing team for Osteoporosis
- 2012 Award of Excellence for Best collaboration between Global Health Outcomes and Market Access team for Osteoporosis
- 2012 Merck Retention Award(2 years retention)
- 2009 Jenkins Knevel award for outstanding Research, October 2009
- 2009 Poster Presentation Competition Finalist at the 13th Annual International ISPOR Conference, May 2008, Toronto, Canada.
- 2008 Best Poster in Social and Behavioral Sciences, Sigma Xi Scientific Society Annual Graduate Student Research Awards Competition, April 2009, West Lafayette, Indiana
- 2008 Graduate Scholar, Regenstrief Center for Healthcare Engineering
- 2008 International Society for Pharmacoeconomics & Outcomes Research (ISPOR) Distinguished Service Award, May 2008
Publications & Professional affiliations
- Ankita is a lead author on more that 15 publications and a co-author on more than 50+ publications, abstracts and posters. Publication bibliography is available upon request
- Ankita is a peer reviewer in 6 and on the editorial board of 2 journals
- Ankita is currently affiliated to professional societies including ISPOR, EPA, HTAi, ASCO, AMCP and APA
Languages
English
Hindi
Gujarati
Marathi
Timeline
Senior Director and Access Strategy lead secondment
Gilead Sciences
03.2024 - 12.2024
Senior Director and HEOR TA head
Gilead Sciences
01.2023 - Current
Senior Director and HEOR TA head
Gilead Sciences
01.2022 - 12.2022
Director and Virology HEOR lead
Gilead Sciences
07.2020 - 01.2022
Director and Retina Lead
Allergan
02.2019 - 06.2020
Director
Merck & Co., Inc.
07.2012 - 01.2019
Associate Manager
Merck Sharp and Dohme
08.2010 - 07.2012
Graduate Research Assistant
Purdue University
08.2007 - 05.2010
Intern
Pfizer
06.2007 - 08.2007
Graduate Teaching Assistant
Purdue University
08.2006 - 05.2007
Graduate Research Assistant
Purdue University
08.2005 - 07.2006
Graduate Assistant
University of Louisiana at Monroe
01.2004 - 08.2005
Summer Intern
Indoco Remedies
05.2002 - 07.2002
Master of Science - Pharmacy
University of Louisiana at Monroe
Bachelor in Pharmaceutical Sciences -
University of Mumbai
Ph. D - Pharmacy
Purdue University